跳至主要内容
临床试验/ACTRN12622000668707
ACTRN12622000668707尚未招募未知

The efficacy of a Precision Health Application for Type 2 Diabetes: a randomised-controlled trial.

Avondale University0 个研究点目标入组 100 人开始时间: 2022年5月6日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
35 Years 至 65 Years(—)
性别
All

入选标准

  • Individuals aged 35 to 65yrs who have been determined to meet the following criteria:
  • They have a:
  • A diagnosis of type 2 diabetes within the last 24 months and are not currently taking insulin
  • Classification of pre-diabetes by a medical practitioner

排除标准

  • Currently experiencing heart failure, or has a previous diagnosis of heart failure
  • Pregnant, breastfeeding or planning pregnancy in the next 12-18 weeks
  • Once deemed eligible for the study, unwilling to wait up to 11 weeks to enter the program
  • Currently taking warfarin or another anti-coagulant
  • Any other contraindications identified by the individuals medical practitioner

研究者

发起方
Avondale University

相似试验